CBLL - NASDAQ

CeriBell, Inc.

CBLL·NASDAQ

$18.63

+6.5%

HealthcareMedical - Devices

CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$706.87M

EPS-1.4600

P/E Ratio-12.76

Earnings Date08/04/2026

cbll

Stock Based Compensation

Last Annual Value

12.22M

3-Year CAGR

16%

5-Year CAGR

10-Year CAGR

Adjust for Inflation

CeriBell, Inc. Competitors Analysis of Stock Based Compensation

CBLL · NASDAQ

Company	Stock Based Compensation	CAGR 3Y	CAGR 5Y	CAGR 10Y
CeriBell, Inc. NASDAQ:CBLL	12.22M	65.9%	N/A	N/A
Treace Medical Concepts, Inc. NASDAQ:TMCI	33.82M	24.9%	58.2%	N/A
Standard BioTools Inc. NASDAQ:LAB	29.61M	31.2%	13.0%	7.9%
Butterfly Network, Inc. NYSE:BFLY	23.43M	-5.2%	-13.3%	N/A
Enhabit, Inc. NYSE:EHAB	16.60M	23.1%	35.8%	N/A
OrthoPediatrics Corp. NASDAQ:KIDS	17.78M	19.1%	24.9%	30.4%
Quantum-Si incorporated NASDAQ:QSI	10.77M	8.2%	-15.4%	N/A
Semler Scientific, Inc. NASDAQ:SMLR	862.00K	N/A	2.9%	11.1%
Varex Imaging Corporation NASDAQ:VREX	15.00M	3.6%	1.5%	N/A
Surmodics, Inc. NASDAQ:SRDX	8.22M	2.6%	7.0%	7.9%

CeriBell, Inc. Fair Value Envelope

CBLL · NASDAQ

Our analysis suggests that CBLL has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $18.63, this represents a potential HIDDEN relative to our calculated worth for CeriBell, Inc..

HIDDEN

Intrinsic Value

Current Price: $18.63

Related Guides

Blog Categories

Continue your CBLL research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.